News about Drug Discovery & Development

AstraZeneca Unveils Broadest Haematology Data Set Yet at ASH 2025

AstraZeneca is advancing its ambition to transform haematology care with new data from its expanding pipeline and portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from 6–9 December 2025.

Drug Discovery & Development | 05/12/2025 | By Darshana |  455

GSK Showcases New Advances in Blood Cancer Treatments

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, reinforcing the potential of its therapies to redefine outcomes for patients with difficult-to-treat blood cancers.

Drug Discovery & Development | 03/12/2025 | By Darshana |  192

JFCR, NEC and Taiho Partner on Whole-Genome Driven Cancer Vaccine Research

JFCR, NEC, and Taiho have launched a joint research initiative to develop novel cancer vaccines using whole-genome data. The project is part of AMED’s national programme on whole-genome analysis, supporting efforts to demonstrate its clinical utility and build systems that translate genomic insights into patient benefits.

Drug Discovery & Development | 01/12/2025 | By Dineshwori |  134

Imugene and JW Therapeutics Collaborate to Advance onCARlytics and Carteyva Combination in Solid Tumours

Imugene and JW Therapeutics have partnered to explore a new combination for refractory solid tumours, pairing Imugene’s onCARlytics (CF33-CD19) oncolytic virus with JW’s CD19 CAR-T therapy, Carteyva. The collaboration will begin with pre-clinical studies and advance to a Phase 1 investigator-initiated trial in China targeting hard-to-treat cancers.

Drug Discovery & Development | 01/12/2025 | By Dineshwori |  186

Zydus Pharma Secures USFDA Approval for Generic Hypertension Drug

Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration to market Telmisartan tablets, a generic version of a commonly prescribed blood pressure medication.

Drug Discovery & Development | 26/11/2025 | By Darshana |  311

Alkem Launches De Simone Formulation Probiotic DSS in India

Alkem Laboratories has introduced DSS, the original De Simone formulation probiotic blend, to the Indian market for restoring gut microbiota balance and managing a wide range of gastrointestinal conditions.

Drug Discovery & Development | 24/11/2025 | By Darshana |  589

HRV Pharma, MetroChem Form Multi-Year CDMO Alliance for High-Value API Development

HRV Global Life Sciences (HRV Pharma), India’s first integrated virtual API and pharmtech company, has entered into a multi-year CDMO partnership with MetroChem API, a leading player in API development and manufacturing.

Drug Discovery & Development | 19/11/2025 | By Darshana |  237

Alembic Secures US FDA Approval for Migraine Treatment Autoinjector

The approved product is therapeutically equivalent to the reference-listed drug, Imitrex STATdose System, priorly marketed by GlaxoSmithKline.

Drug Discovery & Development | 11/11/2025 | By Darshana |  215

ClearPoint Neuro Acquires IRRAS to Boost Neuro Drug Delivery Portfolio

Its cornerstone product is the IRRAflow system, a US FDA-cleared and CE-marked platform which integrates continuous irrigation, aspiration, and real-time intracranial pressure monitoring.

Drug Discovery & Development | 10/11/2025 | By Darshana |  390

US FDA Grants Six More Priority Review Vouchers to Accelerate Drug Approvals

The US Food and Drug Administration (FDA) has awarded six additional companies under its “Commissioner’s National Priority Voucher” programme, bringing the total number of recipients to fifteen.

Drug Discovery & Development | 07/11/2025 | By Darshana |  223